John C. Martin
✓ Source-basedfallingAmerican chemist and businessman
John Charles Martin was an American billionaire businessman, and the former executive chairman (2016-2018) and CEO (1996-2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development.
Also inDeutsch
Photos 1
Awards 2
Connected to John 6
Marvin H. CaruthersAlso won NAS Award for Chemistry in Service to Society
Alejandro ZaffaroniAlso won Biotechnology Heritage Award
William J. RutterAlso won Biotechnology Heritage AwardPaul S. AndersonAlso won NAS Award for Chemistry in Service to Society
John D. RobertsAlso won NAS Award for Chemistry in Service to Society
Nancy T. ChangAlso won Biotechnology Heritage AwardAbout this person
John Charles Martin was an American billionaire businessman, and the former executive chairman (2016-2018) and CEO (1996-2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development. Gilead is known for developing drugs such as Atripla and commercializing Sovaldi (sofosbuvir) for the treatment of the liver virus hepatitis C. Martin is the recipient of a number of awards, including the Biotechnology Heritage Award (2017).
United StatesFame.am measures public visibility signals. It does not measure human value, talent, morality, or credibility.